FDA Inspection 1306576 — Ivan R. Batlle, MD

Ivan R. Batlle, MD — FEI 3030773796

The FDA completed an inspection of Ivan R. Batlle, MD on Apr 17, 2026 in Lenexa, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 17, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Lenexa, KS (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.